Matches in Wikidata for { <http://www.wikidata.org/entity/Q64222171> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64222171 description "clinical trial" @default.
- Q64222171 description "ensayu clínicu" @default.
- Q64222171 description "klinisch onderzoek" @default.
- Q64222171 description "клінічне випробування" @default.
- Q64222171 name "Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML" @default.
- Q64222171 type Item @default.
- Q64222171 label "Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML" @default.
- Q64222171 prefLabel "Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML" @default.
- Q64222171 P1132 Q64222171-0D94E339-9EFC-4B5B-98D4-F8C3935A0425 @default.
- Q64222171 P1476 Q64222171-136FE6B7-D256-4BA5-AF02-6CCA2866FB02 @default.
- Q64222171 P17 Q64222171-8B439637-68B3-4996-86E7-689EBB00C5D2 @default.
- Q64222171 P2899 Q64222171-E326D638-F774-42F8-9062-D24E7958808E @default.
- Q64222171 P3098 Q64222171-CC75A17E-23E4-4EF4-8C13-CC1962E76283 @default.
- Q64222171 P31 Q64222171-846EE0C4-3DAC-41F1-A410-8966A1B45930 @default.
- Q64222171 P580 Q64222171-3FED2867-5A79-4AFF-842E-96BE1C970A0A @default.
- Q64222171 P582 Q64222171-D1BCD6E9-026D-46ED-B27B-CB9B093B1DFA @default.
- Q64222171 P6099 Q64222171-77B5E99D-606A-4517-902B-9FAEE473290A @default.
- Q64222171 P6099 Q64222171-B447948A-93DE-40B2-82B2-C53CB6542291 @default.
- Q64222171 P6153 Q64222171-2E2DEA07-C14E-43EE-B2DE-FCC92763C094 @default.
- Q64222171 P6153 Q64222171-32050A48-4FAC-4B38-B9DC-99D7DF4DAB8D @default.
- Q64222171 P6153 Q64222171-70EF7563-A900-4C4F-BFBA-7677B75703DD @default.
- Q64222171 P6153 Q64222171-AA6D5942-4666-4319-8236-464D9E6E5D4B @default.
- Q64222171 P6153 Q64222171-D889196E-AD68-4862-B05C-B807EE0F57E8 @default.
- Q64222171 P6153 Q64222171-EE63DADA-1DB4-43A0-971A-F3D010BFD04D @default.
- Q64222171 P8363 Q64222171-B15978F7-347B-464A-B8FE-5F87D413E61A @default.
- Q64222171 P921 Q64222171-9FE3BF9D-3D53-4791-9AAE-213297B38B44 @default.
- Q64222171 P1132 "+49" @default.
- Q64222171 P1476 "Multicenter Phase I/II Trial of Ruxolitinib in Combination With Decitabine in Patients With Accelerated Phase Myeloproliferative Neoplasm (MPN) or Post-MPN AML" @default.
- Q64222171 P17 Q30 @default.
- Q64222171 P2899 "+18" @default.
- Q64222171 P3098 "NCT02076191" @default.
- Q64222171 P31 Q30612 @default.
- Q64222171 P580 "2014-02-01T00:00:00Z" @default.
- Q64222171 P582 "2018-07-20T00:00:00Z" @default.
- Q64222171 P6099 Q42824440 @default.
- Q64222171 P6099 Q5452194 @default.
- Q64222171 P6153 Q1808012 @default.
- Q64222171 P6153 Q1950740 @default.
- Q64222171 P6153 Q2415975 @default.
- Q64222171 P6153 Q49117 @default.
- Q64222171 P6153 Q7370121 @default.
- Q64222171 P6153 Q777403 @default.
- Q64222171 P8363 Q78089383 @default.
- Q64222171 P921 Q1304270 @default.